Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)
Others
Ratios

Volitionrx (VNRX) EPS (Weighted Average and Diluted) (2023 - 2025)

Historic EPS (Weighted Average and Diluted) for Volitionrx (VNRX) over the last 4 years, with Q3 2025 value amounting to -$0.05.

  • Volitionrx's EPS (Weighted Average and Diluted) rose 2857.14% to -$0.05 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.23, marking a year-over-year increase of 3233.36%. This contributed to the annual value of -$0.31 for FY2024, which is 3714.28% up from last year.
  • Volitionrx's EPS (Weighted Average and Diluted) amounted to -$0.05 in Q3 2025, which was up 2857.14% from -$0.06 recorded in Q2 2025.
  • In the past 5 years, Volitionrx's EPS (Weighted Average and Diluted) ranged from a high of -$0.05 in Q3 2025 and a low of -$0.12 during Q4 2023
  • Its 3-year average for EPS (Weighted Average and Diluted) is -$0.08, with a median of -$0.07 in 2024.
  • Per our database at Business Quant, Volitionrx's EPS (Weighted Average and Diluted) skyrocketed by 4517.01% in 2024 and then skyrocketed by 2500.0% in 2025.
  • Volitionrx's EPS (Weighted Average and Diluted) (Quarter) stood at -$0.12 in 2023, then soared by 45.17% to -$0.07 in 2024, then rose by 25.32% to -$0.05 in 2025.
  • Its EPS (Weighted Average and Diluted) stands at -$0.05 for Q3 2025, versus -$0.06 for Q2 2025 and -$0.06 for Q1 2025.